BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 16144692)

  • 21. Hypoxia and hypoxia-inducible factors in neuroblastoma.
    Påhlman S; Mohlin S
    Cell Tissue Res; 2018 May; 372(2):269-275. PubMed ID: 29032465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroblastoma aggressiveness in relation to sympathetic neuronal differentiation stage.
    Mohlin SA; Wigerup C; Påhlman S
    Semin Cancer Biol; 2011 Oct; 21(4):276-82. PubMed ID: 21945591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcriptional adaptation of neuroblastoma cells to hypoxia.
    Fredlund E; Ovenberger M; Borg K; Påhlman S
    Biochem Biophys Res Commun; 2008 Feb; 366(4):1054-60. PubMed ID: 18155155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of a prometastatic gene expression program in hypoxic neuroblastoma cells.
    Poomthavorn P; Wong SH; Higgins S; Werther GA; Russo VC
    Endocr Relat Cancer; 2009 Sep; 16(3):991-1004. PubMed ID: 19423615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoxia-mediated histone acetylation and expression of N-myc transcription factor dictate aggressiveness of neuroblastoma cells.
    Poljaková J; Groh T; Gudino ZO; Hraběta J; Bořek-Dohalská L; Kizek R; Doktorová H; Eckschlager T; Stiborová M
    Oncol Rep; 2014 Apr; 31(4):1928-34. PubMed ID: 24481548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypoxia alters the recruitment of tropomyosins into the actin stress fibres of neuroblastoma cells.
    Glass JJ; Phillips PA; Gunning PW; Stehn JR
    BMC Cancer; 2015 Oct; 15():712. PubMed ID: 26475688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for hypoxia-induced neuronal-to-chromaffin metaplasia in neuroblastoma.
    Hedborg F; Ullerås E; Grimelius L; Wassberg E; Maxwell PH; Hero B; Berthold F; Schilling F; Harms D; Sandstedt B; Franklin G
    FASEB J; 2003 Apr; 17(6):598-609. PubMed ID: 12665472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
    Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
    Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HMGI(Y) and HMGI-C genes are expressed in neuroblastoma cell lines and tumors and affect retinoic acid responsiveness.
    Giannini G; Di Marcotullio L; Ristori E; Zani M; Crescenzi M; Scarpa S; Piaggio G; Vacca A; Peverali FA; Diana F; Screpanti I; Frati L; Gulino A
    Cancer Res; 1999 May; 59(10):2484-92. PubMed ID: 10344762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of cell death in the tumor microenvironment.
    Wouters BG; Koritzinsky M; Chiu RK; Theys J; Buijsen J; Lambin P
    Semin Radiat Oncol; 2003 Jan; 13(1):31-41. PubMed ID: 12520462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD44-high neural crest stem-like cells are associated with tumour aggressiveness and poor survival in neuroblastoma tumours.
    Vega FM; Colmenero-Repiso A; Gómez-Muñoz MA; Rodríguez-Prieto I; Aguilar-Morante D; Ramírez G; Márquez C; Cabello R; Pardal R
    EBioMedicine; 2019 Nov; 49():82-95. PubMed ID: 31685444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human neuroblastoma tumor cell lines correspond to the arrested differentiation of chromaffin adrenal medullary neuroblasts.
    Cooper MJ; Hutchins GM; Cohen PS; Helman LJ; Mennie RJ; Israel MA
    Cell Growth Differ; 1990 Apr; 1(4):149-59. PubMed ID: 1982060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histone chaperone CHAF1A inhibits differentiation and promotes aggressive neuroblastoma.
    Barbieri E; De Preter K; Capasso M; Chen Z; Hsu DM; Tonini GP; Lefever S; Hicks J; Versteeg R; Pession A; Speleman F; Kim ES; Shohet JM
    Cancer Res; 2014 Feb; 74(3):765-74. PubMed ID: 24335960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypoxia/reoxygenation: a dynamic regulator of lysyl oxidase-facilitated breast cancer migration.
    Postovit LM; Abbott DE; Payne SL; Wheaton WW; Margaryan NV; Sullivan R; Jansen MK; Csiszar K; Hendrix MJ; Kirschmann DA
    J Cell Biochem; 2008 Apr; 103(5):1369-78. PubMed ID: 17685448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breast tumor-initiating cells isolated from patient core biopsies for study of hormone action.
    Marsden CG; Wright MJ; Pochampally R; Rowan BG
    Methods Mol Biol; 2009; 590():363-75. PubMed ID: 19763516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas.
    Wiesener MS; Münchenhagen PM; Berger I; Morgan NV; Roigas J; Schwiertz A; Jürgensen JS; Gruber G; Maxwell PH; Löning SA; Frei U; Maher ER; Gröne HJ; Eckardt KU
    Cancer Res; 2001 Jul; 61(13):5215-22. PubMed ID: 11431362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transforming growth factor-beta 1 differentially regulates proliferation, morphology, and extracellular matrix expression by three neural crest-derived neuroblastoma cell lines.
    Rogers SL; Cutts JL; Gegick PJ; McGuire PG; Rosenberger C; Krisinski S
    Exp Cell Res; 1994 Apr; 211(2):252-62. PubMed ID: 8143771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered chromosomal methylation patterns accompany oncogene-induced transformation of human bronchial epithelial cells.
    Vertino PM; Spillare EA; Harris CC; Baylin SB
    Cancer Res; 1993 Apr; 53(7):1684-9. PubMed ID: 8453642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential expression of N-myc in phenotypically distinct subclones of a human neuroblastoma cell line.
    Foley J; Cohn SL; Salwen HR; Chagnovich D; Cowan J; Mason KL; Parysek LM
    Cancer Res; 1991 Dec; 51(23 Pt 1):6338-45. PubMed ID: 1933896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptional response to hypoxia in human tumors.
    Lal A; Peters H; St Croix B; Haroon ZA; Dewhirst MW; Strausberg RL; Kaanders JH; van der Kogel AJ; Riggins GJ
    J Natl Cancer Inst; 2001 Sep; 93(17):1337-43. PubMed ID: 11535709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.